DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 3819--------------------------------------------------
       (ECTRIMS) 2-year Ocrevus effective for early MS patients
       By: agate Date: October 26, 2022, 10:42 pm
       ---------------------------------------------------------
       This is a drug-company-sponsored study, and it deals with only 2
       years after initiating treatment with Ocrevus, but the account
       of this presentation at the annual ECTRIMS conference (October
       26-28) has been getting some media attention.
       From Multiple Sclerosis News Today (October 26,
       2022)--"#ECTRIMS2022: 2-Year Ocrevus Effective for Early MS
       Patients":
  HTML https://bit.ly/3zjDnOH
       *****************************************************